Normal view MARC view ISBD view

The Role of Positive Inotropic Drugs in the Treatment of Older Adults with Heart Failure and Reduced Ejection Fraction. [Review]

MedStar author(s):

Citation: Heart Failure Clinics. 13(3):527-534, 2017 JulPMID: 28602370Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Cardiotonic Agents/ad [Administration & Dosage] | *Heart Failure/dt [Drug Therapy] | *Heart Failure/pp [Physiopathology] | Age Factors | Aged | Cardiotonic Agents/ae [Adverse Effects] | Humans | Randomized Controlled Trials as Topic | Stroke VolumeYear: 2017 ISSN:

1551-7136

Name of journal: Heart failure clinicsAbstract: Copyright (c) 2017 Elsevier Inc. All rights reserved.Positive inotropic drugs have long been studied for their potential benefits in patients with heart failure and reduced ejection fraction (HFrEF). Although there has been an extensive amount of research about the clinical effects of these drugs in general, few studies examined their effect in older patients. Therefore, there is little or no evidence to guide the use of positive inotropes in older patients with HFrEF. However, recommendations from national heart failure guidelines may be generalized to older HFrEF patients on an individual basis, taking into consideration the basic geriatric principles of pharmacotherapy: start low and go slow.All authors: Ahmed A, Aronow WS, Dooley DJ, Lam PHFiscal year: FY2017Digital Object Identifier:

https://dx.doi.org/10.1016/j.hfc.2017.02.008

Date added to catalog: 2017-06-16

Holdings ( 1 )
Title notes ( 3 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	28602370	Available		28602370

Positive inotropic drugs have long been studied for their potential benefits in patients with heart failure and reduced ejection fraction (HFrEF). Although there has been an extensive amount of research about the clinical effects of these drugs in general, few studies examined their effect in older patients. Therefore, there is little or no evidence to guide the use of positive inotropes in older patients with HFrEF. However, recommendations from national heart failure guidelines may be generalized to older HFrEF patients on an individual basis, taking into consideration the basic geriatric principles of pharmacotherapy: start low and go slow.

English